Corton Capital Inc. Takes $130,000 Position in InfuSystem Holdings, Inc. (NYSE:INFU)

Corton Capital Inc. acquired a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) during the 4th quarter, Holdings Channel.com reports. The firm acquired 15,373 shares of the company’s stock, valued at approximately $130,000.

Other institutional investors have also modified their holdings of the company. BNP Paribas Financial Markets increased its holdings in InfuSystem by 67.9% during the 4th quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company’s stock worth $58,000 after purchasing an additional 2,768 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of InfuSystem by 51.7% during the fourth quarter. Wells Fargo & Company MN now owns 9,286 shares of the company’s stock worth $78,000 after buying an additional 3,165 shares in the last quarter. Legato Capital Management LLC acquired a new stake in InfuSystem in the 4th quarter valued at approximately $85,000. Summit Global Investments bought a new stake in InfuSystem in the 4th quarter valued at approximately $86,000. Finally, Sei Investments Co. acquired a new position in InfuSystem during the 4th quarter worth approximately $90,000. Institutional investors own 71.13% of the company’s stock.

Analyst Upgrades and Downgrades

INFU has been the topic of a number of recent research reports. Sidoti upgraded shares of InfuSystem to a “strong-buy” rating in a report on Tuesday, March 18th. StockNews.com upgraded shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 14th.

InfuSystem Trading Up 15.2 %

NYSE INFU opened at $5.47 on Friday. InfuSystem Holdings, Inc. has a 12 month low of $4.61 and a 12 month high of $9.97. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average of $5.31 and a 200-day moving average of $7.16. The company has a market cap of $114.96 million, a PE ratio of 91.18 and a beta of 1.73.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.